Tiens Biotech Group controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile3 entries
2022
Products cited in U.S. health-fraud materials
FDA materials continued to list several Tiens products in connection with illegal marketing for serious diseases.
2016
FDA warning over serious-disease claims
The U.S. FDA warned Tiens that claims representing products as capable of treating or preventing serious diseases violated U.S. federal food and drug law.
Uganda allegations concerning health claims and recruitment
The Guardian reported allegations that Tiens supplements were presented in Uganda as cures for severe diseases and questioned whether the recruitment structure operated like a pyramid scheme.